Veeva Systems Inc.

NYSE:VEEV

Medical - Healthcare Information Services

Healthcare
$277.20 -1.83%

-$2.83 today

Market cap
$44.88B
Beta
0.95
P/E (TTM)
26.4
EPS (TTM)
$5.76
52W Low $148.05High $310.50

Volume 2.74M

Average 3.01M

VEEV Sales of Investments

Cash received from selling or redeeming investments.

Veeva Systems Inc.NYSE: VEEV

Sales of Investments · Q2 FY2027 · quarter ended Jul 2026

Sales of investments growth accelerates

Q2 FY2027 sales of investments of $675.15M rose 67.6% year over year, ahead of the +24.7% change in trailing-twelve-month sales of investments. Sequentially, it rose 0.6% from the prior quarter. Over 3 fiscal years it compounded at +27.1% a year.

Context

  • Sales of investments amounted to 64.4% of revenue in FY2026, down 4.9 pp from a year earlier.
  • Sales of investments increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +67.6% holds above the trailing-twelve-month pace of +24.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJul 2026
$675.15M+0.6% QoQ
Last fiscal yearJan 2026
$2.06B+8.2% YoY
LTMJul 2026
$2.38B+24.7% YoY
Sales of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+67.6%——
1 year+8.2%——
3-year CAGR+27.1%——
5-year CAGR——
10-year CAGR——

Sales of Investments history

USD · from the cash flow

Latest · FY2026
2.06B USD
Year-over-year change
+8.2%
4-year CAGR
+26.9%

Sales of Investments vs competitors

How VEEV compares with its peers on the latest reported figures

  • VEEV's LTM Jul 2026 sales of investments of $2.38B is the largest of the 5 companies compared; the peer median is $226.06M.
  • Its year-over-year change of +24.7% is the 3rd highest of 5, against a peer median of +19.1%.
  • Sales of investments amounts to 68.8% of revenue for VEEV, versus a peer median of 42.9%.
VEEV Competitors Peer median
Sales of Investments for VEEV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
VEEVVeeva Systems Inc.LTM Jul 2026$2.38B +24.7%+27.1%68.8%
DOCSDoximity, Inc.LTM Sep 2026$518.31M +4.1%+44.3%78.3%
SDGRSchrödinger, Inc.LTM Sep 2026$428.94M +34.1%+0.7%159.3%
HSTMHealthStream, Inc.LTM Mar 2026$23.17M -18.0%—7.4%
IQVIQVIA Holdings Inc.LTM Jun 2026$3M +50.0%—0.0%
Peer median (excluding VEEV) $226.06M+19.1%+22.5%42.9%

Competitors are the stored peer set for VEEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Jan 2022
FY2023
Jan 2023
FY2024
Jan 2024
FY2025
Jan 2025
FY2026
Jan 2026
Net Income427.39M487.71M525.71M714.14M908.91M
Depreciation & Amortization36.97M37.66M37.15M50.93M50.47M
Deferred Income Tax11.08M(127.5M)(105.37M)(112.27M)65.09M
Stock-Based Compensation0000472.7M
Change in Working Capital20.66M7.34M60.82M7.62M(91.94M)
Accounts Receivables(83.08M)(91.09M)(104M)(168.97M)(254.55M)
Inventory00000
Accounts Payables(3M)21.43M(10.23M)(1.96M)6.08M
Other Working Capital106.74M77M175.05M178.55M156.53M
Other Non-Cash Items268.37M375.26M393.03M429.64M9.99M
Operating Cash Flow764.46M780.47M911.34M1.09B1.42B
Capital Expenditures(14.21M)(13.51M)(26.2M)(20.52M)(29.13M)
Acquisitions (Net)(7.78M)0000
Purchases of Investments(1.12B)(2B)(2.7B)(2.58B)(3.13B)
Sales of Investments792.92M1B1.65B1.9B2.06B
Other Investing Activities00000
Investing Cash Flow(346.15M)(1.01B)(1.08B)(700.14M)(1.1B)
Debt Repayment(384K)0000
Common Stock Issued51.54M43.65M62.69M105.54M253.86M
Common Stock Repurchased0000(169.95M)
Dividends Paid00000
Other Financing Activities(55.29M)(63.03M)(78.88M)(79.42M)(93.25M)
Financing Cash Flow(4.14M)(19.38M)(16.19M)26.12M(9.33M)
Effect of Forex Changes(4.66M)(4.99M)(1.78M)(1.74M)919K
Net Change in Cash409.51M(251.58M)(182.98M)414.29M302.45M
Free Cash Flow750.25M766.96M885.14M1.07B1.39B

Veeva Systems Inc.

NYSE:VEEV

Intrinsic Alpha fair value

Locked

Current Price

$277.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.